GMP Biologics Market to Reach US$98.2 Bn by 2033 Accelerates with Biopharmaceutical Innovation - Persistence Market Research

Positive

AI Analysis

Summary

Market research firm projects the global GMP biologics market will grow from US$52.7 billion in 2026 to US$98.2 billion by 2033, driven by biopharmaceutical innovation and rising demand.

Financial Highlights

Revenue

US$52.7 billion in 2026; projected US$98.2 billion by 2033

Guidance

CAGR of 9.3% during forecast period

Importance:2/10

Sentiment:

0.30

GMP biologicsmarket analysisbiopharmaceuticalgrowth forecast

Related Companies

$GBCYD

Read the original article

Published by PR Newswire Pharma on July 29, 2026 5:16 PM

Read Original